RECENT ARTICLE | Discovering New Therapeutic Targets for Alzheimer’s Disease
Effective therapies for neurodegenerative diseases like Alzheimer’s are urgently needed. But developing new drugs is difficult, time-consuming, and expensive, with a high risk of failure. Read to learn how to mitigate risks and increase chances of success with strategic partnerships. Read article from
LEARN FROM OUR EXPERTS | New Chapters of our Quantum Mechanics Series
Quantum Mechanics (QM) and Artificial Intelligence (AI) tools for chemistry are evolving at a tremendously fast pace and have proven to be invaluable for organic and medicinal chemists. Our experts Dr. Qiuyue Wang, Dr. Dong Pan, Dr. Yongsheng Chen, and Dr. John S. Wai have released 6 new chapters to complete the Ebook "Quantum Mechanics for Organic Chemists: An Experimentalist Approach”:
Upcoming Webinar
Join us on November 3rd for a free webinar where panelists from Cerevance, AstronauTX and WuXi AppTec will discuss the novel approaches for developing therapeutics in the field of neurodegenerative disorders.
Throughout these talks, we will explore examples of novel in vitro, in vivo, and ex vivo models and technologies that are currently advancing modern CNS drug discovery.

A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelists.
On-demand Webinars
Watch this webinar to learn more about:
  • Mass spectrometry as a tool for target identification and validation, with a focus on proteomics
  • Small molecule lead generation with mass spectrometry, with a focus on affinity selection mass spectrometry
  • Distribution, metabolism and pharmacokinetics of new modalities through the application of mass spectrometry
Meet us !
Drug Discovery Summit | London, UK
Meet with our scientists at booth #10 to discuss your projects and learn more about our innovative platforms.
On day 1, Nuska Tschammer, Head of DEL Lab Operation, WuXi AppTec HitS will be presenting : "Rapid experimental assessment of target tractability: Fragment and DNA-encoded library screen based approaches" in the session Identification & Validation of Novel Targets.
Meet us at our booth to learn more about our Biology Platform and our tailored solutions for advancing AD research. Attend our presentation to discover our latest models, and discuss your project with our expert Kris Rutten, Director, WuXi Discovery Services.
SITC 2021 | Washington, DC
Meet our scientists on booth 418 or online to get answers to your most pressing immuno-oncology drug discovery questions.